首页> Photodiagnosis and photodynamic therapy> Enhanced effects of photodynamic therapy and celecoxib on the triple‑negative breast cancer MDA‑MB‑231 cell line: Impact on BCL‑2, BAX, and TP53 gene expression.

Enhanced effects of photodynamic therapy and celecoxib on the triple‑negative breast cancer MDA‑MB‑231 cell line: Impact on BCL‑2, BAX, and TP53 gene expression.

导出 LinkOut

翻译打印收藏纠错

第一作者： Fatemeh,Asgari

第一单位： Department of Cellular and Molecular Biology, TeMS.C., Islamic Azad University, Tehran, Iran.

作者： Fatemeh,Asgari ^[1] ; Fatemeh,Javani Jouni ^[2] ; Jaber,Zafari ^[3] ; Soyar,Sari ^[1] ; Parisa,Ashrafi ^[4]

作者单位： Department of Cellular and Molecular Biology, TeMS.C., Islamic Azad University, Tehran, Iran. ^[1] Department of Biochemistry and Biophysics, TeMS.C., Islamic Azad University, Tehran, Iran. ^[2] Department of Pharmacology and Toxicology, TeMS.C., Islamic Azad University, Tehran, Iran. Electronic address: zafari@iau.ac.ir. ^[3] Department of Cellular and Molecular Biology, TeMS.C., Islamic Azad University, Tehran, Iran; Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ^[4]

关键词 Breast cancer cells Celecoxib Photodynamic therapy Photosensitizer